Biomarkers Related to Molecular Targeted Radiotherapies
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 31 December 2025
Special Issue Editor
Interests: endocrine oncology; theragnostics; molecular targeted radiotherapy; Lu-177 dotatate; Lu-177 PSMA; thyroid cancer; prostate cancer; neuroendocrine tumors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
As the clinical paradigm shifts from “treat what you see” to more refined de-escalation strategies, and with the increasing number of clinical trials related to the development of new radiopharmaceuticals for both diagnostic and therapeutic applications across various oncology fields, new challenges are emerging.
Improving patients’ quality of life and survival while minimizing serious side effects is paramount, especially in aging populations often burdened with complex treatment histories and long-standing disease. Therefore, clinicians are seeking either single or composite biomarkers that can help identify patients with aggressive disease, a high likelihood of rapid progression, or those prone to developing clinical events (prognostic biomarkers), as well as biomarkers that can predict a high probability of response to a given therapy (predictive biomarkers).
This Special Issue is dedicated to original work on the advances in molecular biology, imaging, and translational fields of research aiming at identifying or confirming different biomarkers related to molecular targeted radiotherapies.
Dr. Vija Lavinia
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarkers
- molecular targeted radiotherapies
- prognostic biomarkers
- predictive biomarkers
- single or composite biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
